Thank you to leaders of the world's most impactful colorectal cancer organizations around the globe for sharing their expertise and insights during this 2-part program.
Our 3rd Annual Global Colorectal Cancer Congress is available for on-demand viewing.
This virtual event was designed for colorectal cancer advocates interested in increasing their impact.
To get started, click "Videos & Speakers" from
the drop-down menu above.
Questions? Congress@globalcca.org
This fireside chat highlights the Global Colon Cancer Association’s mission and vision for the future.
Our time has come to ensure that where you live should not determine your ability to prevent or survive colorectal cancer.
This can't miss session features chief executive officers from leading colorectal cancer organizations around the globe.
Hear advice from the experts on how you can have the
greatest impact, lessons learned, and more.
Leaders of these impactful and passionate patient advocacy organizations share how they turned personal loss into
action in this powerful roundtable discussion.
The founder of Man Up To Cancer shares his experience with colorectal cancer and building a community for men and those who love them.
Every patient’s experience with cancer should be counted. Learn how all colorectal cancer patients can have a direct impact on the future of cancer research.
Nicole Sheahan, President, Global Colon Cancer Association concludes part 1 of the 2022 Global Colorectal Cancer Congress: Our Time Has Come
A brief overview of what you can expect from part 2 of the 2022 Global Colorectal Cancer Congress from GCCA President, Nicole Sheahan.
Global CRC patient-centered policy roundtable discussion on establishing an advocacy roadmap for organizations and patient advocates to effect change.
President and Managing Director of Stop Darmkanker discusses developing eye-catching campaigns and provides valuable social media tips to engage your audience.
This session discusses the importance of genetic testing for DPD deficiency prior to chemotherapy with Fluorouracil (5-FU) or Capecitabine (Xeloda).
An overview of biologics and biosimilar medicines. Our expert speakers share how advocates can bring the patient voice to biosimilar policies around the world. For more information on biosimilars, check out GCCA's Biosimilars Training Program.
Best practices and communication strategies for patient advocacy organizations to help build relationships, navigate sponsorships, and programming support from the biopharmaceutical industry.
A brief wrap-up of the 2 part event.
Executive Director
Global Colon Cancer Association
President
Global Colon Cancer Association
Chief Executive Officer
Bowel Cancer Australia
President/CEO
Colorectal Cancer Canada
CEO
Digestive Cancers Europe
Founder/CEO
Raymond Foundation
Founder/CEO
SAID NGO
President/Executive Director
The Gloria Borges WunderGlo Foundation
Founder/Executive Director Niola Cancer Care Foundation
Founder
Man Up To Cancer
Clinical Project Director
Broad Institute of MIT and Harvard
CEO
Colorectal Cancer Alliance
President
Global Colon Cancer Association
President
Fight CRC
CEO
Bowel Cancer UK
Managing Director
Stop Darmkanker Foundation
Assistant Professor of Pharmacy, U of Michigan Advocates for Universal DPD/DPYD Testing
Founder
Advocates for Universal DPD/DPYD Testing
Executive Director
Global Colon Cancer Association
Executive Director
Global Biosimilars Regulatory Affairs, Regulatory and R & D Policy Amgen
Senior Director Patient Advocacy, US Co-Lead
Pfizer
Executive Director & Head of Global Advocacy
Bristol Myers Squibb
Executive Director
World Patients Alliance
Join our mailing list to stay up to date with the latest from the Global Colon Cancer Association.
Copyright © 2022 GCCA Congress 2022 - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.